Delivery Order SPE2DB22D3102-SPE2DB24FL0UG
- Not listed
- This contract award, valued at $8,140.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Phytonadione 5 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period through May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,826.26, is for the delivery of Phytonadione 5 mg tablet in 100-count bottles. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Phytonadione 5 mg tablets. The $26,184.56 firm-fixed-price contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Phytonadione 5 mg tablets, valued at $12,969.83. The contract is a Firm Fixed Price Delivery Order with a completion date of September 12, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This is a federal contract award issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,210,645 units of the drug phytonadione in 0.5 mL doses, with a ceiling value of $8,508.35. The contract is a Firm Fixed Price Delivery Order with a completion date of June 9, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp is the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.17 firm-fixed-price delivery order contract is for the supply of 4561452281 Phytonadione 5 mg Tablets in 30s. The contract has a performance period through July 11, 2023 and was not set aside for any specific business category. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs)...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Phytonadione 10 mg/mL ampul. The contract has a ceiling value of $4,893.23 and a period of performance through July 7, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $1,446.14. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, consistent with AmerisourceBergen's typical federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,031.76, is for the supply of 4564713474 Phytonadione 1 mg/0.5 ml syrup 0.5 ml. The delivery order is placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide phytonadione 10 mg/ml ampules. The contract has a ceiling value of $2,838.75 and an ultimate completion date of April 14, 2025. This appears to be a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FL0UGDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564183153 - Phytonadione 5 mg Tablet 30s. The contract has a ceiling value of $6,804.72 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 4/5/24 |